traditional methods for the generation of Dna damage are not well suited for the observation of spatiotemporal aspects of damaged chromosomal loci. We describe a protocol for the derivation of a cellular system to induce and to visualize chromosome damage at specific sites of the mammalian genome in living cells. the system is based on the stable integration of endonuclease I-sceI recognition sites flanked by bacterial LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (lacr/tetr) to visualize the LacO/TetO sites. expression of the I-sceI endonuclease induces double-strand breaks (DsBs) specifically at the sites of integration, and it permits the dynamics of damaged chromatin to be followed by time-lapse microscopy. sequential laco-I-sceI/teto-I-sceI integrations in multiple chromosomes permit the generation of a system to visualize the formation of chromosome translocations in living cells. this protocol requires intermediate cell culture and molecular biology skills, and it is adaptable to the efficient derivation of any integrated clonal reporter system of interest in ~3-5 months.
IntroDuctIon
Maintaining the integrity of genetic information is essential for the survival of cells. Mechanisms that counteract DNA damage ensure cellular homeostasis, suppress mutagenic events and prevent genome rearrangements that may lead to disease 1 . Recent reports have highlighted the role of higher-order chromatin structure, chromatin dynamics and the nonrandom organization of the genome in the maintenance of genomic integrity [2] [3] [4] . These studies explored the biological implications of chromatin dynamics by following intact and damaged chromatin in living cells. Most currently available methodologies used for these studies are indirect and involve tracking of repair foci formed by fluorescently tagged repair proteins after DNA damage [5] [6] [7] [8] [9] , the incorporation of labeled deoxy-NTP (dNTP) analogs during replication [10] [11] [12] or the expression of core histones tagged with photoactivatable fluorescent proteins after laser-induced DNA damage 13 . Although considerable insights into repair dynamics have emerged from these studies, these methods are limited in their ability to probe the dynamics of specific gene loci or damaged chromosome sites in the cell nucleus.
Here we present a protocol for the generation of a cell-based system that can be used to induce and to visualize DSBs in specific chromosomal sites in mammalian cells for the exploration of dynamics in various chromatin states and genomic environments. The approach is based on the generation of cell lines that contain, stably integrated into their genomes, the 18-nt recognition site for the yeast endonuclease I-SceI, which is not present in mammalian cells. The I-SceI site serves as a means to induce a DSB in a controlled manner by the introduction of the I-SceI restriction enzyme by exogenous expression. The I-SceI site is flanked by bacterial LacO/TetO operator array sequences, which serve to visualize the chromosome ends after in vivo cutting with I-SceI (Fig. 1) . The DNA arrays can be visualized as discrete dots owing to the binding of fluorescently tagged LacR and/or TetR repressor proteins to their cognate LacO and TetO arrays 14, 15 .
The protocol describes the preparation of LacO/TetO repeatcontaining plasmids and the generation of cell lines that carry stably integrated LacO/TetO repeats (Steps 1-36). Procedures are described for effective integration and expression of the fluorescent repressors, which require the generation and selection of optimized cell lines for microscopy using bicistronic retroviral vectors (Steps [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] . The protocol also provides guidelines for the controlled and efficient formation of DSBs at specific chromosome sites by transient expression of the endonuclease (Steps 57-76). The visualization and tracking of chromosome ends in space and in time is then possible by time-lapse fluorescence microscopy (Steps 77-86). We have successfully used the protocol outlined here to generate cell-based systems to probe the dynamics of chromosome ends and to visualize the formation of chromosome translocations in living mammalian cells 16, 17 .
Applications of the protocol
Integration of endonuclease sites flanked by the Lac or Tet operator/ repressor system has been the basis of several models to probe the spatial dynamics of DNA repair in the eukaryotic nucleus and to visualize genomic loci in yeast, fly, Caenorhabditis elegans and mammalian cells [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . For instance, tracking the chromosome ends flanking an engineered DSB suggested that broken ends are positionally stable in mammalian cells 17 . This strategy is also particularly useful for the analysis of the motion properties of specific intact and damaged loci 4 . Moreover, it was recently used to generate a cellular system in which distinct DSBs marked by Lac and Tet operator/repressors on different chromosomes were tracked to reveal the spatial dynamics of chromosome translocations in living cells by high-throughput microscopy 16 . Similarly, in yeast Saccharomyces cerevisiae, engineered integrations of LacO and TetO operator arrays in the vicinity of an inducible DSB and on the corresponding unbroken site on the homologous chromosome have been used to detect increased motion of yeast chromosome breaks engaged in homology search for recombinational repair partners 27, 28 .
This protocol outlines the steps in the generation of cell lines to visualize chromosome breaks, but the approach is readily adaptable to all applications that require visualization of chromosomal loci within the mammalian genome [29] [30] [31] or the integration of any fluorescent reporter of interest [32] [33] [34] [35] . Furthermore, this approach can be used to specifically target and tether proteins of interest (expressed as chimeric fusions with the LacR/TetR repressors) to operator sites integrated in different genomic locations with different chromatin characteristics [36] [37] [38] [39] . This methodology has been successfully used to target repair factors to chromatin, and it has revealed the hierarchy of protein interactions within the DNA repair cascade and suggested the presence of amplification signaling loops 36, 37 . Similarly, targeting of the VP16 acidic activation domain via the LacO/LacR system has been shown to result in transcriptional activation and re-distribution/expansion of chromatin 32, 40 , whereas HP1 tethering to chromatin has been shown to cause condensation 41 . Further applications are the de novo creation of nuclear bodies 42, 43 , or the in vivo testing of protein-protein interactions 44, 45 . Recently, this approach was used to tether the FokI endonuclease to a LacO operator array to induce multiple DSBs within the locus and reveal that DNA damage silences transcription in cis 34 .
Limitations of the protocol
Control of I-SceI expression. In the described protocol, DSBs are induced after transfection of the endonuclease I-SceI by nucleofection. Although transient transfection of I-SceI induces DSBs with high efficiency, the downside of this approach is the uncertainty of the timing of DSB induction because of the nonsynchronized expression of the I-SceI protein, thus limiting its usefulness for kinetic studies that require the coordinated formation of DSBs. This limitation can be overcome by the expression of I-SceI fused to portions of the glucocorticoid receptor (GR-I-SceI), which retains the fusion protein in the cytoplasm until it is stimulated with glucocorticoid receptorbinding steroid hormone. Upon hormone binding, the fusion translocates rapidly into the nucleus, which results in the synchronized induction of breaks in a time-controlled manner 17 . Once it is induced, however, the enzyme is constitutively active, and it continues cutting intact sites as soon as they are repaired, thus making tracking of repair kinetics difficult. This limitation may eventually be overcome by the expression of I-SceI as a chimera with a degron, allowing its controlled degradation 46 .
Insertion site location. This protocol describes the steps for random integrations of the array plasmids into the genome, which precludes analysis of preselected genomic sites. However, the location of integration sites may be controlled by the use of established gene-targeting methods using sequence-specific targeted cleavage events such as transcription activator-like effector nucleases 47 and clustered regularly interspaced short palindromic repeats-associated nucleases (CRISPR) 48 . These methods enable the targeted formation of DSBs at defined genome sites of interest, substantially increasing the efficiency of recombination 47, 48 .
Array size. The manipulation of the LacO/TetO long repeated sequences requires diligence due to their intrinsic susceptibility to recombination and instability 18 . We provide here important information for the development and propagation of repeat-containing plasmids of up to ~20 kb in size. Larger transgene arrays with long genomic DNA inserts require different cloning strategies and manipulations using bacterial artificial chromosomes 49 .
Imaging requirements.
We provide an outline of the steps required for visualization of the broken chromosome ends by highthroughput time-lapse microscopy. We describe a protocol using a high-end imaging system (Perkin-Elmer OPERA), and although automated imaging is required to capture the rare events of chromosome translocations in living cells 16 , less advanced instruments equipped with an environmentally controlled chamber and a typical epifluorescence unit or confocal setup are sufficient to follow DSBs in time and sufficient for many other applications of tagged genomic loci. The motion dynamics of DSBs or intact chromosome loci can then be assessed by calculating the mean squared displacement, as described in detail elsewhere 22 .
Comparison with other methods
Other methods to induce DNA damage and to visualize spatial dynamics of DNA repair include irradiation with alphaparticles 6, 50 , UV damage 51 , laser-induced damage [52] [53] [54] [55] , radiomimetic drugs 56, 57 or gamma-irradiation 5, [58] [59] [60] . In contrast to the protocol described here, those methods produce damage indiscriminately throughout the genome, which complicates the assessment of the effects of spatial genome organization and the local chromatin environment in the DNA damage response. Although DSBs can be induced in a recurrent and site-specific manner by taking advantage of the presence of endogenous I-PpoI 61 16 . This protocol specifically details the steps that are required for optimized repressor expression and maximum detection rate.
Recent studies have successfully applied transcription activatorlike effector nuclease and CRISPR/Cas9 technologies to visualize endogenous repeated genomic sequences 64, 65 . Visualization of endogenous repetitive loci by these methods coupled with the induction of DSBs in the same loci could in theory be used to assess the spatial dynamics of endogenous gene loci bearing repetitive sequences. Furthermore, using modifications of the CRISPR system and arrays of single guide RNAs (sgRNAs) tiled along a specific chromosomal target locus, recent work enabled the visualization of nonrepetitive genomic sequences for the first time, allowing for the possibility of visualizing any genome location in living cells 64 . Although these tools have tremendous potential, they have not been applied to the study of DNA damage, and the current detection sensitivity is insufficient for live-cell imaging 64 .
Experimental design
Manipulation of plasmids containing repeated Lac and/or Tet operator (LacO/TetO) sequences adjacent to the I-SceI endonuclease site. The propagation and manipulation of long repeated array sequences requires careful handling of the plasmids carrying the repeats owing to the high instability of the repeated sequences during replication in Escherichia coli. We have successfully used Stbl2 competent cells to transform plasmids containing array sequences. The instability of the plasmids is minimized by propagating bacteria at 30 °C and by selecting smaller-sized colonies from LB agar plates. As high yields of these plasmids are required for ensuing steps in the protocol, large-scale plasmid purification must be achieved. We have noticed increased instability of these constructs during large-scale preparations, and thus highly recommended testing the integrity of the propagated plasmid by restriction fragment analysis at each step (Fig. 2) . Alternatively, multiple smaller preps (minipreps) that have been verified by restriction analysis may be pooled together to achieve sufficiently large quantities of DNA. Standard commercial DNA plasmid preparation kits can be used to extract the plasmid DNA, and typically a minimum of 20 µg of each plasmid is required for the subsequent protocol steps. If additional cloning steps are required (e.g., addition of a reporter assay cassette and so on), it is highly recommended to use the plasmids containing the repeated sequences as the template to insert the sequence of interest, as we have empirically found that this decreases the probability of array recombination after transformation of the ligation products.
Generation and selection of stable cell lines with LacO/TetO integrated arrays. To facilitate the identification and selection of clones with integrations of the LacO/TetO I-SceI plasmids, we cotransfect the cells of interest with a second plasmid encoding a gene conferring resistance to an antibiotic (pSV40-Zeocin/ pTRE2-hygromycin, respectively). To increase the percentage of cells bearing integrations of both the array plasmid and the selectable marker, cells are transfected with the respective plasmids at a 10:1 ratio, both linearized to increase plasmid integration efficiency. It is essential to carefully titrate the antibiotic dose for each cell line to determine the minimum lethal dose. For plasmid delivery, we routinely use electroporation-based methods (Amaxa nucleofection) or standard cationic lipid-based methods. By using the former, ~10-20% resistant clones that are positive for LacO/TetO integrations can typically be isolated, but this may substantially vary depending on the cell line, plasmids and selection drugs. Optimal plating density of the transfected cells in the presence of the selection drug will ensure the formation and isolation of monoclonal cell lines (Supplementary Fig. 1 ). The integration of LacO/TetO plasmids can be confirmed by the transient expression of fluorescently tagged LacR/TetR repressors using conventional cationic lipid-based methods to deliver the plasmids. Positive clones can then be isolated on the basis of the stability, position and number of the integrations after examination under a standard epifluorescence or confocal microscope (Fig. 3a) . In case of polyclonal cells (mixed population of cells), replating of cells at a low density may allow isolation of monoclonal lines. Clones of interest are further expanded, and stocks are frozen during early passages. If the integration of different arrays at distinct chromosome sites in the same cell line is desired, sequential transfection and establishment of stable cell lines by repeating the stable cell line production protocol for each integrant is recommended (Fig. 3b) .
Stable integration of the fluorescent LacR/TetR repressors to visualize the LacO/TetO operators and selection of optimal cell lines.
To develop cell lines that stably express the LacR and/or TetR repressors, we used bicistronic retroviral expression vectors (pQCXIP and pQCXIN, respectively) that were designed to express the GFP-LacR and TetR-mCherry along with different selection markers (puromycin and neomycin, respectively; Supplementary Fig. 2a ). These plasmids are co-transfected into the packaging cell line Platinum GP (Plat-GP) with a plasmid encoding the viral envelope VSV-G protein. Plat-GP cells stably express the retroviral structure proteins encoded by gag and pol genes and show high transfectability if they are transfected at optimal confluency (Supplementary Fig. 2b ). We routinely achieve high transfection efficiency (≥70-90%) with the nonliposomal vehicle FuGENE HD. Depending on the investigator's expertise and preference, other transfection methods such as cationic lipid-based methods or calcium phosphate transfection may also be tested 66 . The fluorescent LacR or TetR repressors and the puromycin or neomycin resistance genes are cotranscribed by a cytomegalovirus (CMV) immediate-early promoter as a bicistronic message via an internal ribosome entry site, and thus they confer long-term resistance only to the cells expressing the repressors. The selection process is very efficient, and typically 6 ml of the retroviral vector-containing supernatant produced by the packaging cell line from a 10-cm plate (2 d after transfection) is sufficient to transduce ~1.2 × 10 6 NIH3T3 cells plated in three wells of a sixwell plate. It is essential to carefully titrate the antibiotics in any cell line that is used to determine the minimum lethal dose. As the strong binding of the LacR and TetR repressors to the respective operators may interfere with cellular functions such as replication and transcription 67 , it is essential that the clones be maintained in the presence of isopropyl β-D-1-thiogalactopyranoside (IPTG) and doxycycline to prevent the binding of the LacR and TetR to their respective operators. Washing out these drugs will then permit the binding of the fluorescent repressors and the detection of the arrays by microscopy ( Fig. 4a) . In general, low expression of the fluorescent repressors is required for optimal detection of the integrated arrays ( Supplementary Fig. 3 or by manually selecting sparsely plated clones showing optimal expression.
Expression of the endonuclease I-SceI to induce DSBs and time-lapse microscopy. To induce DSBs specifically at the locations where the I-SceI restriction sites have been integrated, the yeast I-SceI endonuclease can be expressed using different strategies. Transient transfection by electroporation (nucleofection) permits the expression of I-SceI as soon as 4-6 h later, and it can be achieved with high transfection efficiency. Typically, up to 80% of cells express I-SceI after electroporation, as judged by the detection of an immunofluorescence signal 24 h later. We routinely use a version of I-SceI tagged with the hemagglutinin (HA) epitope 68 , which permits the detection by immunofluorescence microscopy of the cells expressing the endonuclease (Fig. 4b) . By using this protocol, DSBs can be specifically induced with high efficiency at specific genome sites, as judged by the recruitment of repair factors, such as 53BP1, only in cells expressing the enzyme (Fig. 4b) . To follow the dynamics of the formed DSBs, time-lapse fluorescence microscopy can be used. To capture the rare formation of translocations within the mammalian nucleus, we follow individual DSBs over time by high-throughput time-lapse microscopy, acquiring a total of 840 time-lapse movies with 1-h intervals for up to 24 h (ref. 16 ; Fig. 5 ). Figure 5 | High-throughput time-lapse microscopy to follow DSB dynamics. Cells described in Figure 4a were transfected with the I-SceI plasmid, and 6 h later time-lapse microscopy was performed to follow DSBs marked by the LacO (green dots) and TetO (red dots) for up to 20 h. Maximal projected image sequences are shown. Scale bar, 10 µm. EQUIPMENT SETUP Opera high-content screening system The Opera high-throughput microscopy system used in these studies is equipped with four diode lasers for
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sample illumination (405, 488, 560 and 640 nm). It is also equipped with three high quantum efficiency cooled charge-coupled device (CCD) cameras for simultaneous acquisition of multiple fluorescence channels, to prevent bleed-through between the channels. The cameras are located in the light path behind the Nipkow spinning disc unit, providing confocality for the captured digital image data. REAGENT SETUP DMEM FBS 10% (vol/vol), 2 mM l-glutamine, 100 units/ml Pen and 100 µg/ml Strep Mix 500 ml of DMEM with 50 ml of FBS, 5 ml of l-glutamine and 
2|
To each tube, add 5 µl (~50 ng) of plasmid DNA containing arrays of repeated sequences adjacent to the endonuclease I-SceI recognition site (e.g., LacOI-SceITetO, LacOI-SceI and TetOI-SceITetO). Move the pipette up and down while dispensing. Gently tap the tube to mix the contents.  crItIcal step Use sterile reagents and equipment, and take careful measures against contamination in this step and in all subsequent steps.
3|
Incubate the cells on ice for 30 min.
4|
Heat-shock the cells in a 42 °C water bath for 25 s.  crItIcal step Do not shake the cells.
5|
Place the tubes on ice for 2 min.
6|
Add 0.9 ml of SOC medium at RT and shake it at 225 r.p.m. at 30 °C for 90 min.
7| Spread 100 µl from each tube onto an individual LB agar plate containing 100 µg/ml ampicillin. Incubate the plates at 30 °C for ~16-20 h. As bacteria grow at a slower rate at 30 °C, incubation for additional time may be required. Frequently check the size and number of colonies to determine the optimal incubation period.
8| Day 2. Pick 5-10 single colonies from each transformation and inoculate them in 2-3 ml of LB medium containing 100 µg/ml ampicillin. Incubate the colonies at 30 °C while shaking at 225 r.p.m. for 12-16 h.  crItIcal step Pick small colonies, as there is a higher probability that they contain intact, nonrecombined plasmids (which are more difficult to replicate, and thus grow at a slower rate). 
9|
12|
Add to each digestion 2 µl of the 6× loading dye and load into the wells of a 1% (wt/vol) agarose gel (in 1× TAE) supplemented with 1× GelRed. Analyze the restriction fragments by electrophoresis in 1× TAE buffer at 5 V/cm for 20-40 min. Visualize and capture the gel image on a gel documentation system. Mark the DNA minipreps that show the expected restriction fragments (Fig. 2a,b) .
13|
Inoculate 0.5 ml of any bacterial culture (from Step 8) showing the expected restriction pattern (Step 12) into 250 ml of LB medium supplemented with 100 µg/ml ampicillin in a 1,000-ml flask. Incubate the culture at 30 °C while shaking at 225 r.p.m. for 16-20 h.
14| Day 4.
Transfer 0.75 ml of each bacterial culture into a microcentrifuge tube and add 0.25 ml of 50% (vol/vol) glycerol to prepare a glycerol stock. Store it at −80 °C.  pause poInt Glycerol stocks of recombinant E. coli can be stored at −80 °C indefinitely, and they can be used to initiate bacterial cultures for subsequent plasmid preparations.
15|
Transfer the remainder of the bacterial cultures into polypropylene bottles and pellet the bacteria by centrifugation at 6,000g for 15 min at 4 °C. Discard the supernatant.  pause poInt Bacterial pellets can be stored at −20 °C for up to 1 month for plasmid DNA extraction at a later time.
16|
Proceed with plasmid DNA extraction using the Qiagen Plasmid Maxi Kit according to the manufacturer's instructions. Elute DNA with 200 µl of nuclease-free water and resuspend it to a final concentration of 1 µg/ml.  pause poInt Plasmid DNA can be stored at −20 °C indefinitely or at 4 °C for several months.
17|
Repeat Steps 10-12 to verify the integrity of the DNA preps by restriction endonuclease analysis. 
Generation and selection of cell lines with stable
19|
Perform phenol/chloroform extraction (Box 1). Alternatively, run digestions (load each digestion in three separate wells to prevent overloading) on a 1% (wt/vol) agarose gel (in 1× TAE) supplemented with 1× GelRed at 5 V/cm for 20-40 min. Check digestions and expected restriction fragments on a gel documentation system and cut linearized plasmids. Gel-extract using the Qiagen Qiaex II Gel extraction kit according to the manufacturer's instructions, and resuspend the products in water.
20|
Transfect linearized TetOI-SceITetO and pTRE2Hyg plasmids at a 10:1 ratio by using the Amaxa Nucleofector according to the manufacturer's instructions for the cell line of interest. For integrations into NIH3T3 cells, electroporate using the program U-030 a total of 1 × 10 6 cells, resuspended in 100 µl of the R solution, with 3 µg of TetOI-SceITetO and 0.3 µg of pTRE2Hyg, and plate the electroporated cells in three wells of a six-well culture dish containing DMEM at a final volume of 2 ml. Note that incorporation of the resistance cassette (conferring hygromycin resistance) into the TetOI-SceITetO plasmid using additional cloning steps will remove the need for co-transfection, and it will increase the efficiency of the selection.
21| Day 2.
Wash the cells with 1× PBS twice, trypsinize them using 0.25% (wt/vol) trypsin-EDTA and plate the cells in a 150 × 25 mm tissue culture dish in DMEM in a total volume of 25 ml. Add the drug for selection. Plate the same number of untransfected cells to use as a positive control for the drug selection.  crItIcal step Cell density and homogeneous dispersion in this plating step are important to enable recovery and screening of single-cell colonies.  crItIcal step Different cell lines show distinct resistance to drugs. In pilot experiments, determine the optimal lower lethal dose for each cell type by titrating the drug concentration. . 1) , use the P200 pipette at 200-µl volume and P200 tips to simultaneously scratch and draw up individual colonies into the tip, and immediately transfer them into individual wells of 24-well plates containing 1 ml of DMEM supplemented with the selection drug. Incubate the mixture at 37 °C, 5% CO 2 .
The number of the isolated colonies may vary according to the efficiency of the procedure. Typically, 30-50 colonies are isolated and processed further.
24|
Days [17] [18] [19] [20] . Wash the cells with 1× PBS, trypsinize with 50 µl of 1× trypsin-EDTA 0.25% (wt/vol) and mix well by shaking strongly forward and backward and side-to-side. Add 1 ml of fresh medium and incubate it at 37 °C, 5% CO 2 . Replenish the medium every 3 d until the cells reach confluency. The time required to reach confluency may vary owing to distinct proliferation rates of the different clones. 
25|
27|
Mix the contents of tube 1 and tube 2 together, and incubate them at RT for 10 min.
28|
Aspirate the medium from the wells and add 500 µl of the reaction in a dropwise manner on top of cells or coverslips.
Incubate the mixture at 37 °C, 5% CO 2 for 6 h. Replace it with fresh medium and incubate overnight at 37 °C, 5% CO 2 .
29| Day 22.
Aspirate the medium and wash the cells twice with 1× cold PBS. Fix the cells by adding 1 ml of 4% PFA per well at RT for 10 min.
30|
Wash the cells three times using 1× PBS, by shaking the plate for 5 min during each wash.
31|
Remove the wash buffer and add 1 ml of Hoechst solution to the wells by incubating in the dark for 15 min at RT to stain the nuclei.
32|
Wash away the excess stain using 1× PBS.
33| Dispense 10 µl of mounting medium on the top of a microscope slide. Use forceps to place each coverslip on top of the mounting medium in a way that cells are in contact with the mounting medium and the microscope slide, without introduction of air bubbles. Seal the edges of the coverslips on the microscope slides by applying clear nail polish. Allow it to dry for at least 1 h protected from light.
34| Day 23.
Examine the slides using a standard epifluorescence or confocal microscope. Search for clones containing TetOI-SceITetO integrated arrays visualized as distinct spots (Fig. 3a) . (Fig. 3b) . Both LacOI-SceI and pSV40Zeocin plasmids can be linearized with ScaI. For NIH3T3 cells, Zeocin should be added at 300 µg/ml for selection.  crItIcal step Stable LacO/TetO cell lines can be maintained in culture even in the absence of selection 16 . Split cells at a 1:3 ratio when the cells reach 90% confluency. It is recommended to initially prepare several frozen aliquots of low-passage cells for future use. 
Generation of
37| Day 1.
Thaw a vial of Plat-GP cells quickly at 37 °C. Transfer the contents into a 15-ml conical tube containing 10 ml of Plat-GP cell medium. Centrifuge the cells at 500g at RT for 5 min, and discard the supernatant. Resuspend the cells in 10 ml of Plat-GP medium, transfer them into a 100-mm dish and incubate them at 37 °C, 5% CO 2 for 24-48 h until the cells reach 80-90% confluency.  crItIcal step Low-passage Plat-GP cells need to be used for higher efficiency of viral production. It is recommended to initially prepare several frozen aliquots of low-passage cells in good condition for future use, as the growth rate of Plat-GP cells is inversely correlated with passage.
38| Day 2.
Aspirate off the medium, wash the cells gently once with 1× PBS and trypsinize by adding 1 ml of trypsin-EDTA. After the cells visibly detach, add 5 ml of Plat-GP cell medium and thoroughly pipette up and down using a 10-ml pipette until a single-cell suspension is achieved.
39| Replate 3 ml in each of two 100-mm dishes, and add 7 ml of Plat-GP cell medium. To homogeneously disperse the cells, move the dishes forward and backward and side-to-side on a flat surface and incubate them at 37 °C, 5% CO 2 for ~24 h or until the cells reach 80-90% confluency (supplementary Fig. 2b) . Freeze down the cells of one of the plates as in Step 35 .  crItIcal step In order to reach maximum transfection efficiency, Plat-GP cells should not be plated too sparsely or to the point of overconfluence (supplementary Fig. 2b) . Optimal density for high transfection efficiency is 80-90%, which can be typically reached 24 h after splitting 80-90% confluent cells at a 1:2 ratio.
40| Day 3.
Inspect the cells to ensure 80-90% confluency. Gently replace the medium with 10 ml of Plat-GP cell medium prewarmed to 37 °C for each 100-mm dish, and incubate it at 37 °C, 5% CO 2 for 1 h before transfection.
41|
Prepare the plasmid-transfection reagent complex for each 100-mm plate of Plat-GP cells by mixing 490 µl of Opti-MEM with 2 µg of pVSV-G, 4 µg of pQCXIP-GFPLacR and 4 µg of pQCXIN-TetRmCherry in a microcentrifuge tube and incubate it at RT for 5 min.
42| Add 30 µl of FuGENE HD, gently mix it once and allow the complexes to form for 20 min at RT.
43|
Dispense 500 µl of the complex solution dropwise on top of Plat-GP cells + medium, and gently move the dishes forward and backward and side-to-side on a flat surface to mix well in the medium. Incubate the dishes at 37 °C, 5% CO 2 for 16 h. ! cautIon Note that Plat-GP cells produce live virus; use appropriate biosafety level practices from this point forward.
44| Day 4.
Check the transfection efficiency of Plat-GP cells with the fluorescent repressor plasmids on an inverted fluorescence microscope equipped with the appropriate filters.
? trouBlesHootInG 45| If the transfection efficiency is optimal (70-90%), aspirate off the medium and replace it gently with 6 ml of prewarmed Plat-GP medium per plate. Incubate the plates at 37 °C, 5% CO 2 for ~24 h to allow virus production. The formation of syncytia by fusion of Plat-GP cells is normal owing to the VSV-G protein expression.
46|
Trypsinize the selected stable LacO/TetO array cell line generated from Step 36. Count 1.2 × 10 6 cells and plate them into three wells of a six-well plate at confluencies in the range of 2 × 10 5 , 4 × 10 5 and 6 × 10 5 cells. Supplement DMEM to a final volume of 2 ml per well.  crItIcal step The final nuclear expression of LacR and TetR repressors is crucial for the optimal visualization of the LacO and TetO arrays. Titration of cell confluency will provide infected cells with variable expression of the repressors, allowing subsequent selection of the optimal expression levels. Typically, low expression of the fluorescent repressors is essential for discrete visualization of arrays over the free nucleoplasmic fraction (supplementary Fig. 3 ).
47| Day 5.
Collect the virus-containing supernatant and replace it with 6 ml of prewarmed Plat-GP medium per plate and incubate it at 37 °C, 5% CO 2 for ~24 h.
48|
Filter the supernatant through a sterile 0.45-µm filter. Aspirate off the medium from the LacO/TetO cells and replace it with 2 ml of the filtered supernatant. To prevent binding of the expressed LacR and TetR repressors to the respective operators, supplement each well with 5 mM IPTG (10 µl of 1 M stock) and 1 µg/ml doxycycline (2 µl of 1 mg/ml stock), and incubate at 37 °C, 5% CO 2 for ~24 h.  crItIcal step IPTG is unstable. Replenish the medium supplemented with IPTG every 2-3 d. 
49|
54| Day 17.
Fix cells from the 24-well plates and mount them on a microscope slide as described in Step 33. Examine the slides using a standard epifluorescence or confocal microscope. Select clones in which both LacO and TetO arrays are clearly visible (Fig. 4a) .
55| . Expand the selected cell clones from the six-well plate (from Step 53) to a 100-mm dish. 
56|
62|
Add to the transfected cells 1 ml of DMEM and plate 250 µl each in four wells of a 24-well plate containing a coverslip. Add DMEM to a final volume of 1 ml and incubate the cells at 37 °C, 5% CO 2 for 12 h.
63|
Aspirate off the medium and wash cells twice with 1× cold PBS.
64|
Fix the cells by adding 1 ml of 4% PFA per well at RT for 15 min.
65| Wash the cells 3 times using 1× PBS (by shaking the plate for 5 min during each wash).
66|
Permeabilize the cells by adding 1 ml of 0.3% (vol/vol) Triton X-100 and incubate them at RT for 5 min.
67| Wash the cells three times using 1× PBS (shaking the plate for 5 min during each wash), and add 1 ml of blocking buffer for 1 h at RT.
68| Dilute (1:500) the rat monoclonal antibody against the HA epitope of the I-SceI and the rabbit polyclonal antibody against 53BP1 (1:1,000) in blocking buffer.
69|
Transfer the coverslips from the 24-well plates using forceps to a layer of Parafilm within a 150 × 20 mm tissue culture dish with cells facing up.
70|
Remove any excess blocking buffer and dispense 100 µl of the antibody dilution on top of the coverslips. Incubate the mixture for 1-2 h at RT or leave it overnight at 4 °C.  crItIcal step Place a wet paper wipe in the dish to create a humidified chamber and to avoid evaporation.
71|
Place each coverslip, cell side up, in a well of a six-well plate supplemented with 2 ml of 0.1% (vol/vol) Tween-20, and wash it three times (by shaking the plate for 5 min during each wash).
72| Prepare the secondary antibody dilutions. Use Alexa Fluor anti-rat 647 for detecting HA diluted in blocking buffer (1:500) and Alexa Fluor anti-rabbit 405 for detecting anti-53BP1 (1:500 in blocking buffer). Use forceps to transfer the coverslips back to the chamber, dispense 100 µl of the secondary antibody dilution and incubate for 1 h at RT protected from light.  crItIcal step Different combinations of primary/secondary antibodies can be used according to the particular needs of the experiment, the primary/secondary antibody availability and the detection capacity by fluorescence microscopy.  crItIcal step Secondary antibody dyes are light-sensitive; protect them from light using aluminum foil at all subsequent steps.
73|
Place each coverslip in a well of a six-well plate containing 2 ml of 0.1% (vol/vol) Tween-20 and wash it three times (by shaking the plate for 5 min during each wash).
74| Place 10 µl of fluorescence mounting medium on a microscope slide. Use forceps to place each coverslip on top of the mounting medium such that the cells are in contact with the mounting medium and the microscope slide, without introducing air bubbles. Seal the edges of the coverslips on the microscope slides by applying clear nail protector. Allow it to dry for 1 h, protected from the light.
75|
Examine the slides using a standard epifluorescence or confocal microscope. Determine the percentage of cells that are positive for the active form of the enzyme (HAI-SceI) or the inactive mutant (HAI-SceID44A), and show colocalization of the LacO or TetO arrays with the formed 53BP1 repair foci (Fig. 4b) . 78| Switch on the OPERA high-content screening system and use the climatization control software to equilibrate the incubator to 37 °C. Wait for ~30 min until the temperature is reached, and set it at 60% humidity and 5% CO 2 .  crItIcal step Keep the temperature at 37 °C while the humidity is turned on to avoid condensation of water and instrument damage. For each exposure acquisition, select the optimal best focus height and click the 'take height' button when satisfied. Determine the optimal laser intensity for each different exposure by clicking at EXPOSE, and adjust the laser power and exposure time as desired. Save the exposure parameters.
79|
81|
Create the plate layout marking the desired wells that you want to image. Open the NAVIGATE tree, right-click on the experimental folder and select CREATE LAYOUT. Follow the layout wizard to select the desired wells, and click on FINISH.
Similarly create the well sublayout by selecting CREATE SUBLAYOUT in the NAVIGATE tree and select the number and location of the fields per well that will be acquired. For a typical high-throughput experiment to visualize chromosome translocations 16 , 14 adjacent fields per well of a total of 60 wells are sampled; typically, ~1.5 × 10 4 cells are captured in 840 time-lapse movies.
82|
Click on CREATE STACK in the NAVIGATE tree to define the number and the interval of the acquired z stacks. Choose three z stacks with 2-µm interval. , 1 h, 1 h, 1 h, 1 h, 1 h, 1 h, 1 h, 1 h, 1 h, 1 h, 1 h. 
85|
On the RCI Scheduler software press START. The microscope will acquire images of 3 z stacks per field, of 14 fields per well in a total of 60 wells (3 z stacks per field of 840 fields in total) and every 1 h it will repeat the imaging procedure 16 times.
86|
Open the Perkin-Elmer ACAPELLA High-Content Imaging and Analysis Software and use the Interactive Video script to assemble, maximum project and export the acquired time-lapse movies for analysis.
The exported movies can be visually inspected or automatically processed using image analysis scripts, which are generated in Matlab or other advanced image analysis software 16 . Sufficient storage capability to accommodate the large amount of generated images is required.
? trouBlesHootInG Troubleshooting advice can be found in table 1. (Fig. 2) Sub-optimal transfection ratio of the plasmids conferring resistance to the antibiotic and the LacO/TetO plasmid antIcIpateD results By using the protocol described here, propagation of plasmids containing large unstable repeated sequences can be achieved (Steps 1-17) . We have applied this method to propagate plasmids up to ~20 kb in size containing arrays of the LacO and TetO operators adjacent to the restriction endonuclease site I-SceI for the development of stable cell lines in which DSBs can be induced and tracked in space and time 16 . We are able to isolate NIH3T3 cell lines with stable LacO/TetO I-SceI array integrations with efficiency of up to 20% (Steps 18-36). In our recent study 16 , a cell line with three integrations of a TetOI-SceITetO array in distinct chromosomes was isolated and used for the subsequent integration of a LacOI-SceI plasmid. By using this protocol, we then could generate cell lines that stably express the fluorescently tagged LacR and TetR repressors to visualize the arrays with high efficiency 16 . Through the stable integration of bicistronic retroviral vectors that express the LacR and TetR repressors along with genes conferring resistance to antibiotics, as described in this protocol, ~80-90% of the cells stably expressed the LacR and TetR repressors during the initial passages after selection (Steps 37-51). However, we noticed the propensity of cells to lose the GFP-LacR expression with time, which can be overcome by single-cell subcloning or sorting by flow cytometry. Moreover, despite single-cell picking, in some cases, cells expanded from an individual colony typically consist of a mixture of two or more clones with variability in the number of the LacO/TetO integrations and/or the LacR and TetR expression levels. These mixed cell populations can be separated by a second round of single-cell subcloning, using the same procedure described in Steps 52-56. These steps allow the generation of monoclonal cell lines with defined numbers of array integrations and homogeneous LacR and TetR expression levels (Fig. 4a) . Optimize the transfected cell number and plasmid quantity taking account manufacturer's recommendations for the cell line used.
After trypsinization complete procedure within
